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Abstract 17 
Nutrition-related studies avoid the participation of pre-menopausal women due to the potential 18 
effect of the menstrual cycle (MC) on their appetite regulation. It is generally accepted that women 19 
increase their energy intake during the luteal phase (LPh) compared to the follicular (FPh), however 20 
what happens in the menstrual phase (MPh) and how this might be regulated remains uncertain. 21 
Although some research indicates changes in the gastric emptying (GE) velocity, whether PYY is 22 
affected by the MC phase, remains unknown. The aim of this study was to assess whether eating the 23 
same breakfast in each of the three MC phases would change the GE time, the PYY response and post-24 
prandial satiety such that they might affect subsequent food intake. Furthermore, the aim was to 25 
associate any potential differences to the fluctuations in estradiol (E2) and progesterone (P4) within a 26 
MC. Nine naturally cycling women attended to the laboratory to consume a standardised breakfast on 27 
three occasions, each of them representing one of the MC phases. Breath samples to measure GE 28 
time, plasma samples to quantify PYY levels and hunger scores were collected for a total of 4 hours 29 
after which food intake was assessed by an ad-libitum buffet lunch. GE and PYY levels changed 30 
significantly across the phases of the MC (p <0.05). GE was correlated to P4 and E2-P4 ratio (r = -0.5 and 31 
0.4, respectively). To conclude, the appetite regulators PYY and GE time change depending upon the 32 
MC phases with GE time associated with the ovarian hormone levels which suggests the necessity of 33 
controlling the MC phase in studies looking at the appetite response.  34 
 35 
Keywords: menstrual cycle, PYY, gastric emptying, ovarian hormones. 36 
 37 
Abbreviations 38 
AUC Area under the curve 
E2 Estradiol 
EI Energy intake 
FPh Follicular phase 
GE Gastric emptying 
LPh Luteal phase 
MC Menstrual cycle 
MPh Menstrual phase 
P4 Progesterone 
 39 
Tasc Ascension time 
Thalf Half time 
Tlag Lag phase 
Tlat Latency time;  
VAS Visual Analogue Scale 
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Introduction 40 
It is well known that the process of digesting food involves numerous actions by different organs 41 
in order to prepare food for its absorption in the intestine. This action is regulated by different gastric 42 
and intestinal hormones (e.g. gastrin, cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1)) that will 43 
ensure the availability of the intestine to continue the digestive and absorptive process (Smolin & 44 
Grosvenor, 1994). Peptide tyrosine-tyrosine (PYY) is one of the multiple regulators of the digestion 45 
process and its main role is to mediate the ileal brake, i.e. the delay in the transit of the chyme through 46 
the gastrointestinal tract (Onaga, Zabielski, & Kato, 2002), that results in an increase in satiety. 47 
Furthermore, its satiating action is also known to originate in the central nervous system as PYY can 48 
cross the blood-brain barrier and target areas known to regulate the homeostatic e.g. hypothalamus 49 
and the hedonic e.g. caudolateral orbital frontal cortex, circuits (Batterham et al., 2007). PYY’s 50 
secretion in the distal intestine is stimulated post-prandially and this is related to the caloric and 51 
macronutrient content of the meal (Adrian et al., 1985; Batterham et al., 2003).  52 
Multiple studies have shown how changes in gastric emptying (GE) speed and PYY response to a 53 
meal-test can have an impact on appetite sensations and subsequent food intake (Clegg & Shafat, 54 
2010; Stoeckel, Weller, Giddings, & Cox, 2008). Nevertheless, many of the studies conducted in this 55 
area avoid the participation of women or control their protocol by testing women at a specific phase 56 
of the menstrual cycle (MC), as it is generally accepted that women can experience changes in their 57 
habitual food intake upon the phase of their MC (Buffenstein, Poppitt, McDevitt, & Prentice, 1995; 58 
McNeil & Doucet, 2012). These changes seem to result from a bigger meal size (rather than from an 59 
increased number of meals) in the luteal phase (LPh) than the follicular (FPh) (Asarian & Geary, 2013). 60 
Therefore, it could be suggested that women may experience changes in their food intake due to 61 
fluctuations experienced primarily in their satiation (the process of finishing meal), rather than their 62 
satiety (the process inhibiting the start of a meal), throughout the MC.  63 
In fact, Brennan et al. (2009), who assessed food intake from a buffet 90 min after providing a 64 
glucose load to nine healthy women on three days of the MC (two in the FPh and one in the LPh), 65 
found that food and energy intake (EI) during LPh was significantly higher compared to FPh (~50 g and 66 
~700 kJ difference, respectively). This was related to a faster emptying of the stomach, the time 67 
needed for emptying 50% of the gastric glucose during LPh was 15 min less than during the FPh. In 68 
addition, there was a higher post-meal release of GLP-1, blood glucose and plasma insulin levels in the 69 
LPh, thus the glycaemia response was improved when P4 was low in the FPh. Finally, CCK response 70 
showed no changes despite the differences in hunger and EI between phases. Nevertheless this was 71 
not entirely unexpected as CCK secretion seems to be more affected by fat and protein intake rather 72 
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than glucose (Liddle, Goldfine, Rosen, Taplitz, & Williams, 1985). Whether modifications in the 73 
appetite responses are maintained with a full breakfast and whether there would be any differences 74 
during the menstrual phase (MPh) has not been previously studied. The latter seems of importance 75 
as both ovarian hormones, estradiol (E2) and progesterone (P4), are found at very low concentrations, 76 
in contrast to the other two phases. Having a better understanding of women’s appetite physiology 77 
seems imperative in light of the global higher obesity prevalence in women than men (WHO, 2015). 78 
The objective of the present study was to assess whether eating the same breakfast in each of 79 
the three MC phases would change the GE time, PYY response and satiety feelings of the meal to 80 
ultimately have an impact on the food intake of a buffet lunch served four hours later. Furthermore, 81 
the aim was to associate any potential differences to the naturally occurring fluctuations in E2 and P4 82 
of the MC. We finally aimed to investigate whether food intake recorded during three days for each 83 
MC phase changed significantly. 84 
 85 
Material and methods 86 
Participants 87 
Participants were recruited by posters placed in Oxford Brookes University facilities e.g. library, 88 
sport centre, student accommodation, and also in local libraries or gyms, as well as on social media. 89 
Moreover, the study was advertised in the Oxford Brookes University Research Activity Group, on the 90 
Functional Food Centre website and in the volunteers section of a local website. 91 
 The inclusion criteria comprised of women between 18-40 y with regular MC for the last three 92 
months that lasted between 25 and 35 days and excluded those who were taking hormonal 93 
contraceptives, were pregnant, lactating or had any metabolic/genetic diseases or taking any 94 
medications known to interfere with their metabolism. In addition, participants who had an 95 
allergy/intolerance to any of the foods given in the study, did not consume breakfast and lunch 96 
habitually or were attempting to lose weight were also excluded. Finally, smokers and participants 97 
with a disease (e.g. Gilbert's syndrome) or taking medication known to interfere with appetite (e.g. 98 
codeine) or those who showed to be restrictive eaters were also excluded. The latter was assessed by 99 
the combination of two adapted restrictive eating questionnaires: the Dutch Eating Behaviour 100 
Questionnaire (DEBQ) (van Strien, Frijters, Bergers, & Defares, 1986) and the Three-factor eating 101 
questionnaire – restraint eating (TFEQ FI) (Stunkard & Messick, 1985). Participants with a TFEQ score 102 
of >10 and a DEBQ >2.5 were considered restrictive eaters and were excluded from participating in 103 
the study. 104 
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Ethical approval for the study was obtained from the University Research Ethics Committee at 105 
Oxford Brookes University. All participants gave written informed consent prior to commencing the 106 
study. 107 
 108 
Protocol 109 
Once the participant agreed to participate in the study, she was given a fertility monitor (Clear 110 
Blue Advanced Fertility Monitor, Clearblue) to assist in the scheduling of visits to the laboratory based 111 
on the three different MC phases i.e. MPh, FPh and LPh. The three chosen days were aimed to display 112 
a very distinguishable profile in the ovarian hormones: MPh, E2 and P4 at low concentrations; FPh, E2 113 
at high concentrations while P4 remains low; and LPh, E2 and P4 at high concentrations. The MPh visit 114 
was scheduled as soon as the participant notified the start of a new MC (i.e. day 1) and this was 115 
performed within 4 days of starting the MC. From day 6 of the MC, participants tested their morning 116 
urine using the fertility monitor to measure their oestrone-3-glucuronide (E3G) and luteinising 117 
hormone (LH) levels. When participants obtained the ‘high’ reading (i.e. E3G levels were increased) 118 
they notified the researcher who scheduled the next testing session based on the cycle day of the high 119 
reading, the MC length history of the participant and the fact that it usually takes approximately five 120 
days to reach to ‘peak’ after a ‘high’ reading (Howards et al., 2009), in order to test the participant at 121 
very high levels of E2. Once the ‘peak’ reading (i.e. LH levels were high) appeared, the last session was 122 
scheduled to test when P4 was at its highest values (in the mid-luteal phase) based on the peak day 123 
and the usual MC length of the participant. When participants did not reach ‘peak’ they were asked 124 
to postpone their LPh testing session until the next cycle to ensure that the P4 levels were high enough 125 
to produce any potential effects on the parameters studied (i.e. PYY response, GE time, appetite 126 
feelings and food intake). 127 
Once the visit to the laboratory was scheduled, participants were also asked to record their food 128 
intake for three days in each MC phase: (1) the day before coming to the laboratory, (2) the testing 129 
day and (3) the day after the visit to the laboratory. An example testing timeline within a MC is given 130 
in Fig 1. In addition, participants were asked to wear a body monitoring system (SenseWear®, 131 
BodyMedia) to estimate their PA levels to facilitate the validation of the EI from the food diary and 132 
detect any potential misreporting.  133 
In the evening before each test day, participants were asked to avoid the consumption of caffeine 134 
and alcohol and any strenuous exercise that they would not usually do as part of their normal daily 135 
lifestyle. 136 
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 137 
 138 
Fig 1. Example experiment timeline during a MC. 139 
During the visits to the laboratory, participants were requested to arrive between 7:00-9:30h to 140 
have their body composition assessed by electrical bioimpedance, Tanita Body Composition Analyzer 141 
BC-418MA (Tanita Ltd, West Drayton, UK) and then a cannula (BD Venflon Pro Safety 20GA, Becton 142 
Dickinson Induction Therapy, Singapore) was inserted into a vein of the anti-cubital fosse of the arm 143 
to obtain the baseline blood sample (t = 0). The cannula was kept patent by flushing 0.9% sodium 144 
chloride into the system with a needle-free syringe after collecting each sample. Immediately after, 145 
participants filled in the visual analogue scale (VAS) for appetite sensations and the first breath sample 146 
for the measurement of GE was collected. Then the participant consumed the standardised breakfast 147 
labelled with 13C octanoic acid; the breakfast consisted of scrambled eggs on toast, pineapple and a 148 
drink of their choice (water, coffee or tea with/out milk and sugar). The breakfast was standardised 149 
amongst participants and provided 375-395 kcal of which 35%, 38% and 23% were in the form of fat, 150 
carbohydrate and protein, respectively. The energy provided by the breakfast accounted for 17-18 % 151 
of the total daily energy requirements for an average woman (19-44 years) with median physical 152 
activity level of 1.63 i.e. 2103-2175 kcal/d (SACN 2011). Participants were asked to finish their 153 
breakfast within 15min. As soon as they finished their breakfast, the first post-ingestion breath 154 
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sample, blood sample and satiety scores were collected. Subsequent breath samples were taken every 155 
15 min until 240 min. Subsequent blood samples and satiety scores were taken every 15 min until t = 156 
60 min thereafter every 30 min until t = 240 min (Fig 2). 157 
 158 
Fig 2. Timeline of events during each of the testing days in the laboratory. 159 
Immediately after the last blood sample, the cannula was removed and the participant was 160 
offered an ad-libitum lunch buffet composed by a variety of dishes/foods. The selected foods were 161 
chosen with the aim to satisfy all tastes and possible conditions (e.g. lactose intolerance, vegetarian 162 
diets, etc.) thus food intake was not restrained by choice or quantity (Table 1). Participants were 163 
invited to eat until comfortably full within 30 min.  164 
Table 1. Foods available in buffet lunch with nutritional composition per portion provided. 165 
Food 
Serving Energy Fat 
(g) 
Carbs 
(g) 
Fibre 
(g) 
Prot 
(g) 
Salt 
(g) units g (kJ) (kcal) 
Hummus  50 664 161 14 4 2 4 1 
Apples Gala 1 135 304 71 0 16 2 1 0 
Banana 1 158 636 150 0 36 4 2 0 
Clementines 2 226 398 95 0 20 3 2 0 
Carrots  70 123 30 0 6 2 0 0 
Celery sticks  80 32 8 0 1 1 0 0 
Tomatoes 18 142 119 28 0 4 1 1 0 
Potato Salad *  270 1858 448 35 28 3 4 1 
Tuna & Sweetcorn Pasta 295 2295 549 25 59 3 20 1 
Moroccan Couscous 245 2112 502 16 75 11 9 0 
Bright Salad  83 93 22 0 3 2 1 0 
Cheese, Babybel 4 95 1207 291 23 0 0 21 2 
Low-fat Yoghurt 1 120 406 96 1 19 0 3 0 
Sausages 8 66 779 187 14 7 1 9 1 
Chicken Nuggets 5 77 770 185 10 14 1 10 0 
Cheese & Tomato Pizza 1 160 1934 459 12 68 2 18 1 
Bread sticks  19 331 78 1 14 1 2 0 
Crisps, ready salted 1 bag 24 527 126 8 12 1 1 0 
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KitKat 4 fingers 45 958 229 11 29 1 3 0 
Orange Juice  500 985 230 0 54 0 5 1 
Water  500 0 0 0 0 0 0 0 
Egg Mayonnaise Sandwich * 139 1202 287 13 26 5 14 1 
Chicken Sweetcorn Sandwich* 139 1199 287 12 29 5 14 1 
TOTAL (non-vegan buffet) 3594 17974 4291 184 494 51 142 11 
Bean & Mint Salad ϒ 215 1288 310 13 26 14 15 2 
Soya Fruit Yoghurt ϒ 1 129 396 94 3 12 2 5 0 
Vegetable Spring Rolls ϒ 6 115 1173 281 14 33 3 6 0 
Peanut Butter Sandwich ϒ 113 1477 355 20 23 7 17 0 
Beetroot, Mint hummus Sandwich ϒ 109 755 180 5 23 6 7 1 
TOTAL (vegan buffet)  2914 11413 2721 95 361 62 78 6 
Nutritional composition of the foods was based on manufacturer’s information. Carbs, carbohydrates; Prot, 166 
protein. * Item removed in the vegan buffet. ϒ Item included in the vegan buffet only. 167 
 168 
Measurements 169 
Gastric emptying Breath samples were collected by blowing into a small glass tube (Labco 170 
Exetainer, Labco Limited, UK) through a straw while having the nose blocked with a nose-clip. 171 
Participants blew into the tube while removing the straw to immediately cap the tube which was then 172 
stored at room temperature for analysis. Breath samples were analysed using an isotope ratio mass 173 
spectrometer (ABCA, Sercon Ltd, Chesire UK) to quantify the excess amount of labelled oxidised 174 
octanoic acid (i.e. 13CO2) above baseline for each time point, as previously described elsewhere (Clegg 175 
& Shafat, 2010). This was expressed as the percentage of dose recovered per hour and this was fitted 176 
into a non-linear regression model (Ghoos et al., 1993). From this model several parameters were 177 
measured. Lag phase (Tlag) and half time (Thalf) were calculated using the formulae derived by Ghoos 178 
et al. (1993). Tlag is the time taken to maximal rate of 13CO2 excretion (Jackson, Bluck, & Coward, 2004) 179 
and is equivalent to the time of the inflection point (Schommartz, Ziegler, & Schadewaldt, 1998). Thalf 180 
is the time it takes 50% of the 13C dose to be excreted (Jackson et al., 2004). Latency phase (Tlat) 181 
(Schommartz et al., 1998) is the point of intersection of the tangent at the inflection point of the 13CO2-182 
excretion curve representing an initial delay in the excretion curve. Ascension time (Tasc) (Schommartz 183 
et al., 1998) is the time course between the Tlat and Thalf, representing a period of high 13CO2-excretion 184 
rates (Fig. 3). 185 
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 186 
Fig 3. GE time points (Clegg & Shafat, 2010) 187 
PYY and E2 and P4 levels. Blood samples were collected with K2E-EDTA tubes (BD Vacutainer, 188 
Becton Dickinson, UK). A 4 ml blood sample was withdrawn from the cannula for every time point, 189 
except for the baseline when 8 ml were collected to measure the ovarian hormones. After collection, 190 
blood samples were kept in ice until they were centrifuged at 4°C for 10 minutes at 4000 rpm (MC-6, 191 
Sarstedt Ltd, Leicester, UK) to extract the plasma. These were then frozen at -80°C in different aliquots 192 
until analysis. E2 and P4 levels were measured by an ElectroChemiLuminescense immunoassay (ECLIA) 193 
with a Cobas e411 semi-automated analyser (Roche diagnostics Burgess Hill, UK) and total PYY 194 
concentrations were assessed with a direct sandwich enzyme-linked-immunosorbent assay (ELISA) kit 195 
(EMD Millipore).  Samples of the same participant in the three phases of the MC were analysed within 196 
the same ELISA plate. Averaged intra-duplicates coefficient of variance (CV) for the total PYY ELISA 197 
assay was 6.3 ± 1.4 %. Averaged inter-plate CV for the quality controls of the PYY ELISA assay was 13.3 198 
± 4.1 %. 199 
Appetite sensations. Feelings of satiety were assessed by four questions (1) ‘How hungry do you 200 
feel?,’ (2) ‘How full do you feel?’, (3) ‘How strong is your desire to eat?’ and (4) ‘How much food do 201 
you think you can eat?’ in which participants had to rate their appetite sensations with the VAS, 202 
namely, by putting a mark in a 100 mm line per each question, where 0 = (1) ‘not hungry at all’, (2) 203 
‘extremely full’; (3) ‘not strong at all’ and (4) ‘nothing at all’ and 100 = (1) ‘extremely hungry’, (2) ‘not 204 
at all full’; (3) ‘extremely strong’ and (4) ‘a large amount’. The distance between the origin (score = 0) 205 
and the mark was used to measure the participant’s score.  206 
Ad libitum food intake. The researcher weighed out all the foods before and after the participant 207 
had lunch and then food intake was analysed using an excel spreadsheet designed from the 208 
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manufacture’s food information provided in the food label. Ad-libitum food intake assessment 209 
included the measurement of energy, carbohydrate, protein, sugar, fat, saturated fat, fibre and 210 
sodium.  211 
Food intake from food diaries. For three days of each MC phase participants were asked to weigh 212 
out and record all the foods and beverages consumed with as much detail as possible (e.g. brand, 213 
cooking process). If participants could not weigh out a meal, they were asked to provide portion sizes 214 
by using household measures (e.g. cups) and/or by taking pictures of the foods eaten. The selected 215 
days of each phase included one of the visits to the laboratory (on day 2 of the 3-days), therefore 216 
participants had to only record anything consumed after leaving the testing facilities on the test day. 217 
Food intake recorded was measured by the use of a nutrition analyses software program (Nutritics 218 
V3.74 Professional Edition) and intakes of energy, carbohydrate, sugar, protein, fat, saturated fat, fibre 219 
and sodium were determined per day and per phase of the MC for each participant.  220 
Physical activity. Participants were requested to wear the body monitoring system on the upper 221 
right arm (triceps muscle) throughout the day (24 hours) except during activities in which the skin is 222 
in contact with water (e.g. showering) as the equipment instructions advise (Body Media, 2006). Data 223 
was downloaded and analysed as total daily energy expenditure (kcal/d) using the BodyMedia 224 
software once individual characteristics (i.e. date of birth, height, weight, sex) were entered into the 225 
system. Averaged daily energy expenditure across the same nine days as the food diaries were 226 
recorded. This was then compared to the energy intake estimated from the food diaries. 227 
 228 
Calculations and statistical analyses 229 
PYY peak was defined as the highest PYY concentrations achieved post-baseline. Concentrations 230 
of PYY were used to calculate the total area under the curve (AUC) using the trapezoidal method at 231 
min 60, 120, 180, 210 and 240 from baseline (before breakfast).  232 
Each appetite sensation question was analysed separately by calculating the derived AUC from 233 
the scores of all the time points. AUC was calculated using the trapezoidal method at min 60, 120, 180, 234 
210 and 240 from baseline. The employment of VAS has been validated in many studies and the use 235 
of total AUCs with baseline levels as covariates has been recommended over individual time scores or 236 
incremental AUCs within participants (Blundell et al., 2010). 237 
One-way repeated measures ANOVA or Friedman test was used to test differences across the 238 
phases of the MC for PYY AUCs, ovarian hormone levels, GE parameters and food intake across the 239 
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phases of the MC. When significant differences were found, a Bonferroni post-hoc pairwise 240 
comparison or a Wilcoxon signed-rank test was performed, according to the normality of the data. A 241 
2-way repeated measures ANOVA with time and MC phase as factors was used to analyse the change 242 
in PYY levels from baseline within subjects as an assessment of the post-prandial changes across the 243 
MC. AUC for VAS was analysed with another 2-way repeated measures ANOVA that included the 244 
baseline scores as covariates in the analyses.  245 
Associations between EI and PYY, GE and appetite feelings as well as between ovarian hormones 246 
and the appetite markers (i.e. EI and PYY, GE and appetite feelings) were analysed by Pearson’s or 247 
Spearman’s correlation, according to the normality of the data.  248 
A sample size of nine women was based on the only other study that has looked at appetite 249 
hormones responses in the MC (Brennan et al., 2009). 250 
 251 
Results 252 
Participants characteristics 253 
Fifteen women signed the consent form of which three had to be excluded because of violating 254 
the inclusion criteria (i.e. irregular MC and suspicion of suffering Gilbert’s syndrome). Of the twelve 255 
women who started the study, two withdrew due to personal reasons and another who completed 256 
the study had to be excluded because of unconfirmed ovulation and unavailability to reschedule the 257 
LPh testing day. Thus the following results are based on a population of nine NC women (Table 2). 258 
Table 2. Participants’ characteristics at baseline 259 
 Mean ± SD 
Age (years) 31 ± 6 
Height (m) 1.67 ± 0.09 
Body weight (kg) 63.4 ± 12.8 
BMI (kg/m2) 22.6 ± 2.7 
Fat Mass Percentage (%) 29.0 ± 7.4 
Fat Mass (kg) 19.1 ± 7.8 
Fat Free Mass (kg) 44.4 ± 6.3 
Waist-to-hip ratio 0.77 ± 0.07 
 260 
MC characteristics and ovarian hormones 261 
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Average MC length was 29 ± 3 days. Of the nine participants included, four had a “peak” reading 262 
i.e. ovulation was confirmed by the fertility monitor, within their first MC, while three participants 263 
only ovulated on the second MC. Averaged “peak” reading happened on day 14 ± 3 of the MC. The 264 
two remaining participants were asked to attend to the laboratory when it was expected to be their 265 
mid-LPh despite not having had a peak reading in the fertility monitor. Nevertheless, plasma P4 levels 266 
indicated that these participants had ovulated as P4 concentrations were > 15.9 nmol/L which is 267 
considered high enough to have ovulated (Piers et al., 1995). Moreover, one of these two participants 268 
had a positive LH peak in her personal fertility monitor, thus participants were kept in the study as 269 
they seemed to have ovulated despite not having been detected by the fertility monitor used in the 270 
study. 271 
There were significant differences in E2 and P4 concentrations amongst the three phases of the 272 
MC (p < 0.001 and <0.0001, respectively). E2 levels were significantly increased in the FPh and LPh 273 
compared to the MPh, and P4 levels were significantly higher in the LPh compared to the other two 274 
phases (Fig 4).  275 
 276 
Fig 4. E2 and P4 concentrations in the different phases of the MC (means ± SD). 277 
 278 
GE  279 
There was a significant overall effect of the phase of the MC on Thalf and Tasc (Table 3) but none of 280 
the specific comparisons between phases indicated a significant difference. However the effects 281 
observed seem to suggest trends that Thalf was quicker in the LPh compared to the FPh and the MPh 282 
(mean difference: 28 ± 31 and 13 ± 15 min, p = 0.081 and 0.092, respectively) and Tasc was faster in 283 
the LPh compared to the FPh (mean difference: 27 ± 29 min, p = 0.077). There was a trend towards a 284 
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difference in Tlag across the phases of the MC (p = 0.072). No differences were found in Tlat across the 285 
phases of the MC. 286 
Table 3. GE parameters shown in minutes for MPh, FPh and LPh. 287 
GE parameter (min) MPh FPh LPh p 
Thalf 101 ± 23 116 ± 46 88 ± 22 0.015 
Tlag 48 ± 8 51 ± 14 43 ± 12 0.072 
Tlat 52 ± 7 53 ± 12 48 ± 13 0.264 
Tasc 128 ± 23 143 ± 41 116 ± 13 0.011 
Thalf, half time; Tlag, lag phase; Tlat, latency time; Tasc, ascension time. Mean ± SD 288 
 289 
Total PYY 290 
Due to blood collection issues, a total of four samples (1%) could not be obtained. These were 291 
the 150-240 min samples of one participant’s FPh, therefore, comparisons from min 150 onwards are 292 
only from 8 participants.  293 
PYY levels were significantly different at baseline across the phases of the MC (p = 0.004), being 294 
significantly lower in the LPh compared to the MPh (14.97 ± 10.11 vs 22.81 ± 11.89 pmol/L) (p = 0.008), 295 
but not to the FPh (16.22 ± 7.08 pmol/L, p = 0.079). PYY peak was lower in the LPh compared to the 296 
MPh and FPh (29.20 ± 12.38 vs.33.35 ± 11.83 and 32.94 ± 12.00 pmol/L, respectively) but it was not 297 
significantly different (p = 0.264). 298 
There was a significant overall effect on PYY AUC at t = 60, 120, 180 and 240 min, but only at t = 299 
60 min there was a significant difference between specific phases, i.e. LPh vs. MPh (1157 ± 678 vs.1471 300 
± 650 pmol/ml/min) (p = 0.021) (Fig 5). However the effects observed seem to mainly reflect that the 301 
PYY AUCs at t = 120, 180 and 240 min were smaller in the LPh compared to the MPh (p = 0.066, 0.129 302 
and 0.113, respectively).  303 
14 
 
 304 
Fig 5. Total PYY AUCs at t = 60, 120, 180 and 240 min in the different phases of the MC (means ± 305 
SD). *Significantly different to the LPh within the same time AUC. 306 
The 2-way ANOVA analyses looking at the change in PYY levels from baseline to every time point 307 
showed that only time had a significant effect (p <0.001), whereas phase or phase x time interaction 308 
had no statistical effect on PYY change (p = 0.846 and 0.213, respectively) (Fig 6). 309 
 310 
Fig 6. Change in PYY levels from baseline to each time point in the different phases of the MC 311 
(Means ± SD). 312 
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Satiety ratings 314 
There were no significant differences in AUC for any of the four satiety questions when analysing 315 
them in a two-way-ANOVA (time x phase) with the baseline measurements as covariates. AUC at the 316 
end of the 4 hours test for “how hungry do you feel”; “how full do you feel?” “how strong is your desire 317 
to eat” and “how much food do you think you can eat?” were 6932 ± 2961, 7404 ± 2010 and 7802 ± 318 
2080 mm/min; 8924 ± 3153, 10358 ± 4261 and 10340 ± 3638 mm/min; 7039 ± 3147, 7479 ± 2108 and 319 
8268 ± 2388 mm/min for MPh, FPh and LPh, respectively (Fig 7). 320 
Fig 7. Appetite sensations scores (mm) before and after breakfast in the different phases of the 321 
MC: (1) ‘How hungry do you feel?’ (A), (2) ‘How full do you feel?’ (B), (3) ‘How strong is your desire to 322 
eat?’ (C) and (4) ‘How much food do you think you can eat?’ (D). (Means ± SD) 323 
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Ad-libitum, post-lunch and averaged food intake  326 
For this section of the results, a participant’s data was excluded as her eating behaviour and food 327 
diary analyses showed a strong indication that she was restricting her EI during the ad-libitum buffet-328 
lunch as well as underreporting her food intake in the food diary.  329 
During the buffet lunch there were no significant differences in EI, carbohydrate, protein or fat 330 
intake between phases of the MC (Table 4). Similarly no differences were observed in food intake once 331 
participants left the laboratory. In addition, as an average of the three days in each MC phase, non-332 
significant differences were found in food intake. Finally, food intake as an average of the day before 333 
and after the laboratory visit, i.e. food intake under free-living conditions, did not change significantly 334 
for energy, carbohydrate, fat or protein intake across the MC. 335 
Table 4. Food intake during and after the ad libitum lunch and as an average of the three 336 
measured days in each MC phase. 337 
  MPh FPh LPh 
Ad libitum lunch 
Energy (kcal) 931 ± 193 984 ± 178 956 ± 194 
Carbohydrate (g) 113 ± 20 119 ± 20 116 ± 27 
Fat (g) 38 ± 11 41 ± 10 39 ± 8 
Protein (g) 29 ± 6 30 ± 6 30 ± 7 
    
After Ad libitum lunch 
Energy (kcal) 1131 ± 339 1308 ± 660 1192 ± 485 
Carbohydrate (g) 134 ± 47 156 ± 93 141 ± 54 
Fat (g) 42 ± 14 52 ± 25 56 ± 31 
Protein (g) 43 ± 21 39 ± 16 34 ± 18 
    
Average of 3 days 
Energy (kcal) 2352 ± 358 2368 ± 604 2443 ± 412 
Carbohydrate (g) 271 ± 41 274 ± 70 279 ± 54 
Fat (g) 101 ± 21 97 ± 25 106 ± 22 
Protein (g) 84 ± 17 77 ± 10 85 ± 15 
    
Free-living conditions    
Energy (kcal) 2292 ± 146 2203 ± 598 2386 ± 520 
Carbohydrate (g) 264 ± 52 255 ± 64 270 ± 67 
Fat (g) 103 ± 26 91 ± 26 103 ± 27 
Protein (g) 79 ± 19 70 ± 13 84 ± 20 
Means ± SD 338 
  339 
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Relationships between PYY, GE, appetite feelings and EI 340 
There was a significant moderate correlation between peak PYY and Thalf and Tasc (r = 0.396 and 341 
0.410, p = 0.041 and 0.034, respectively). Moreover, there was a trend for a moderate correlation of 342 
PYY AUC at time 180 and 240 with Thalf and Tasc (r = 0.4 for all, p = 0.08 and 0.07 for Thalf and Tasc 343 
correlations, respectively).  344 
No significant correlations were found between EI and PYY, GE or appetite feelings. 345 
 346 
Relationships between appetite markers and the ovarian hormones  347 
There was a moderate negative correlation between Thalf and Tasc and P4 levels (r = -0.490 and -348 
0.426, p= 0.010 and 0.027, respectively). Moreover, Thalf and Tasc were positively correlated to E2:P4 349 
ratio (r = 0.437 and 0.407, p= 0.023 and 0.035). 350 
There were no correlations between PYY AUCs or peak PYY and the ovarian hormones.  Similarly, 351 
no correlations between appetite sensations or food intake and the ovarian hormones were found. 352 
 353 
Discussion 354 
The aim of this study was to investigate whether appetite responses vary after consuming the 355 
same breakfast in the different phases of the MC. This research is of importance in order to extend 356 
the current knowledge in appetite regulation in a subset of the adult population who seems to be at 357 
a higher risk of developing obesity than men (WHO, 2015). 358 
Our results showed that the time to empty half of the breakfast from the stomach to the 359 
duodenum (Thalf) was significantly different across the phases of MC, being on average 28 and 13 360 
minutes quicker in the LPh compared to the FPh and MPh, respectively. Iit could be suggested that 361 
the reduction in the GE time (represented by Thalf) was because of a significantly shorter Tasc and, 362 
potentially, a faster Tlag in the LPh compared to the other phases.. In the LPh, high GE rates might have 363 
been reached quicker and once attained, these were sustained for a shorter period which resulted in 364 
a reduction of the time required to empty the same amount of food from the stomach when compared 365 
to the other two phases of the MC. Because Tasc was maintained for less time in the LPh, GE rates 366 
achieved during that period had to be of a higher velocity to achieve a shorter Thalf. 367 
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Faster GE during the LPh in comparison to the FPh has previously been described (Brennan et al., 368 
2009), however, others have found opposite results (Gill, Murphy, Hooper, Bowes, & Kingma, 1987) 369 
or no differences (Horowitz et al., 1985; Monés et al., 1993) between these two phases, thus a definite 370 
position in this matter cannot be made with the available evidence. Discrepancies amongst studies 371 
might be due to different test meals in terms of calories and nutrient composition (Horowitz et al., 372 
1985) and the fact that some women might not have ovulated as this was not tested in all studies 373 
(Monés et al., 1993). Furthermore, attention is warranted as our outcome does not only support those 374 
who found differences between the LPh and the FPh (Brennan et al., 2009), but also suggests that the 375 
GE effect seen in the LPh is large enough to be compared to the MPh, as well. As far as we know, this 376 
is the first study to add the MPh as another time point to investigate GE within the MC and our findings 377 
suggest that this should be included in future investigations. 378 
To our knowledge, this is the first investigation to indicate that fasting and post-prandial PYY 379 
levels significantly change amongst the phases of the MC. The results indicate that when participants 380 
are fasted in the LPh there are lower PYY levels compared to the MPh. Moreover, the results suggest 381 
that PYY response is smaller after the consumption of the same breakfast in the LPh compared to the 382 
other MC phases. Nevertheless, the MC effect on the PYY response seems to partly result from the 383 
significant differences found at baseline (when fasted) as the statistical significance was lost when 384 
looking at the change in PYY levels from baseline. 385 
PYY secretion occurs by direct contact depending on the presence of food in the lower intestine 386 
(ileum, colon) where the L-cells are located (Fu-Cheng et al., 1995). Its secretion can also start earlier 387 
via neural or hormonal mechanisms, by digestive events that occur at upper sections of the 388 
gastrointestinal tract, i.e. duodenum and stomach (Fu-Cheng et al., 1995). For instance, there is 389 
evidence that gastrin, which is known to stimulate the production of gastric acid, can inhibit the 390 
release of PYY as seen in rats (Gomez et al., 1996). Meanwhile, the increase in gastric acid 391 
concentrations will trigger the synthesis of PYY as part of the ileal brake of the digestion process, thus 392 
creating a feedback loop between the upper and lower gastrointestinal tract. In some (Adamopoulos, 393 
Dessypris, Xanthopoulos, & Chryssicopoulos, 1982) but not all (Frick, Bremme, Sjögren, Lindén, & 394 
Uvnäs-Moberg, 1990; Uvnäs-Msoberg, Sjögren, Westlin, Anderson, & Stock, 1989) studies, gastrin 395 
levels were elevated in the LPh when compared to the FPh which could partly explain the impairment 396 
in the PYY release and the consequent unavailability to reduce the GE time in the LPh in our 397 
participants. This was supported by the positive correlation found between Thalf and PYY peak and the 398 
tendency for a positive correlation with the PYY AUC at t = 180 and 240 min.  399 
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Another potential mechanism that could have contributed to the different PYY responses would 400 
be changes in the CCK secretion. CCK release after the infusion of long-chain fatty acids in the 401 
duodenum has been shown to up-regulate PYY secretion by CCK-receptor 1 (Degen et al., 2007), thus 402 
if CCK secretion is inhibited in the LPh that could in turn impair PYY release. Brennan et al. (2009) 403 
found that CCK secretion was maintained across the MC, although this could have been influenced by 404 
the fact that participants only ingested a glucose drink and carbohydrates are known to be less 405 
effective in stimulating the CCK than fats (Hildebrand et al., 1990), thus there could still be a potential 406 
for CCK modulating the changes in PYY secretion across the phases of the MC. 407 
One interesting finding of the current study was the significant negative correlation between P4 408 
and Thalf. Despite being only a moderate correlation, our results agree with Brennan et al. (2009) and 409 
corroborate the idea that the ovarian hormones might have an influence on GE. Furthermore, the fact 410 
that the ratio between E2 and P4 is also significantly correlated, suggests that both hormones may 411 
modulate the changes in the GE process. Although our results did not indicate a direct association 412 
between PYY levels and the ovarian hormones, these may have exerted their influence by other factors 413 
involved in the digestive process e.g. GE, other appetite-hormonal secretions. Considering the 414 
naturally occurring changes in E2 levels between the MPh and FPh it seemed necessary to investigate 415 
three rather than two phases and this was corroborated by the outcome of the study. 416 
 Although increases in food intake in the ad-libitum lunch were expected in the LPh as seen in 417 
previous literature (McNeil & Doucet, 2012), our results did not find significant fluctuations in EI or 418 
macronutrient intake across the phases of the MC. This could be due to the fact that the majority of 419 
the food intake of the day (while in the laboratory) was already purposely kept constant, thus leaving 420 
little room for any changes. Nevertheless, food intake under the free-living conditions, which was 183 421 
and 94 kcal/d higher in the LPh compared to the FPh and MPh, respectively, was not significantly 422 
different throughout the MC phases, either. Despite not reaching the statistical significance, 423 
fluctuations were within the spectrum of +50-100 kcal/d which are recognised to be of enough 424 
magnitude to induce the progressive development of obesity (Mozaffarian, Hao, Rimm, Willett, & Hu, 425 
2011).   426 
The unchanged food intake during the lunch buffet may be expected since there were no 427 
significant differences in the appetite sensations post-breakfast, suggesting that food intake was 428 
responding to actual appetite perceptions and not to other extrinsic factors. However, direct 429 
correlations were not found between food intake and appetite sensations which manifest the 430 
difficulty in assessing subjective measurements.  431 
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Although the assessment of food intake in a controlled setting presents important advantages, 432 
such as the availability to accurately quantify what is consumed, it also presents several limitations 433 
that cannot be ignored. For instance, eating behaviour can be altered due to eating in a non-familiar 434 
and unnatural environment, or because of the expectations the participants believe that the 435 
researcher might have (Stubbs, Johnstone, O’Reilly, & Poppitt, 1998). Nevertheless, we tried to 436 
minimise this effect by providing a sensible variety of foods that the participant could be familiar with. 437 
On the other hand, although food diaries can avoid the limitations of the laboratory setting, they can 438 
also present different drawbacks such as the misreporting displayed by one of our participants as well 439 
as in other studies (de Vries, Zock, Mensink, & Katan, 1994). Therefore, both methods agreed on the 440 
idea that there were no significant alterations in food intake throughout the phases of the MC. 441 
Inconsistencies with other studies might rely on the limited sample size, although others have proved 442 
significant differences with the same number of participants (Dalvit-McPhillips, 1983). Thus, 443 
differences between the latter study and ours could partly be due to the dietary assessment 444 
techniques employed i.e. dietary interview during 60 days vs. 9 days of food diaries. Finally, although 445 
PYY response significantly changed throughout the MC, the magnitude of the change (mean difference 446 
in total PYY AUC at min 240 in LPh: 15 and 23% compared to the MPh and FPh, respectively) might not 447 
have been substantial enough to elicit modifications in appetite sensations and subsequent food 448 
intake. 449 
There were limitations to this study. Despite GE time and PYY response showing to be significantly 450 
different across the MC, pairwise comparisons could not achieve the statistical significance and that 451 
could be due to the small sample size or the inter-individual variation. In fact, if applying a t-test to 452 
compare Thalf between the LPh and FPh or MPh, significant differences would have been found; 453 
however, with the ANOVA and the Bonferroni correction, the statistical significance was diminished. 454 
Nevertheless, we employed the same sample size used by previous studies (Brennan et al., 2009). The 455 
current study did not distinguish the two different forms of PYY, i.e. PYY1-36 and PYY3-36. It is well known 456 
that with food intake PYY1-36 is cleaved by the dipeptidyl peptidase IV to PYY3-36 and that only the latter 457 
form has almost exclusive and high affinity to Y-2 receptors of the ARC. This is of relevance as Y-2 458 
receptors are the only subtype of Y-receptors that can induce appetite and body weight suppression 459 
by stimulating the activity of the α-MSH through the inhibition of the NPY release (Ballantyne, 2006). 460 
Thus, although unlikely, changes in the concentrations of total PYY could respond to alterations in the 461 
proportion between the two forms of PYY. Thus it cannot be dismissed that lower PYY response in the 462 
LPh was mainly relying on a diminished PYY1-36 secretion and conversion, therefore, inducing minimal 463 
changes in food intake. Future studies could improve our findings by measuring the two forms of PYY. 464 
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 465 
Conclusion 466 
To our knowledge this is the first study to investigate GE time and PYY response after consuming 467 
the same breakfast three times in the MC in which ovarian hormones, E2 and P4 presented very 468 
distinguishable levels. Our results found significant differences in GE time and PYY response that 469 
suggest the LPh as the quickest in GE time with the smallest PYY response of the all MC phases.. Finally 470 
changes in the GE time could be influenced by the fluctuations in the ovarian hormones. 471 
Further research needs to be done to confirm these findings and to have a better understanding 472 
of the underlying mechanisms for these changes in GE time and PYY response across the MC as they 473 
could potentially direct us to novel dieting strategies in women. Finally, our findings suggest that any 474 
functional food studies aimed to change satiation should take into account the likely modifications in 475 
the processing of food that women might experience throughout the MC by re-testing their products 476 
in the different MC phases to ultimately be able to demonstrate the effects of a dietary intervention 477 
in this population. 478 
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